Diabetic Gastroparesis Treatment Market 2024-2033: Size, Share, Growth, Trends, Analysis, Forecast | Outlook, Mergers and Acquisitions, Top Major Key Players, Competitive Landscape

The diabetic gastroparesis treatment market size has grown strongly in recent years. It will grow from $3.68 billion in 2023 to $3.86 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increasing diabetes prevalence, limited treatment options, rising awareness and diagnosis, healthcare infrastructure development.

The diabetic gastroparesis treatment market size is expected to see strong growth in the next few years. It will grow to $4.73 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to precision medicine and personalized therapies, growing diabetic population, increased research and development, shift in regulatory landscape. Major trends in the forecast period include technological innovations in treatments, emergence of novel therapies, focus on symptom management, telemedicine and remote monitoring, gut microbiome interventions.

Market Overview -
Diabetic gastroparesis is a condition in which high blood glucose levels damage the stomach muscles and nerves, leading to delayed gastric emptying and other symptoms. Diabetic gastroparesis treatment refers to the medical interventions and management strategies employed to alleviate symptoms and improve the overall well-being of individuals with this condition. The treatment approach may involve several interventions to address delayed stomach emptying and associated gastrointestinal symptoms.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12580&type=smp

Rising Diabetes Prevalence Ignites Momentum In Diabetic Gastroparesis Treatment Market
The increasing prevalence of diabetes is expected to propel the growth of the diabetic gastroparesis treatment market going forward. The prevalence of diabetes refers to the proportion or percentage of the population that has been diagnosed with diabetes at a specific point in time. The use of diabetic gastroparesis treatment is primarily aimed at managing the symptoms and complications associated with this condition, which is a common complication of diabetes. For instance, in April 2023, according to a report published by The British Diabetic Association, a UK-based diabetes charity, 4.3 million individuals in the UK have diabetes and live with it. Further, more than 2.4 million people in the UK are at high risk of acquiring type 2 diabetes, and registration numbers for 2021-22 are 148,951. Therefore, the increasing prevalence of diabetes is driving the growth of the diabetic gastroparesis treatment market.

Competitive Landscape -
Major companies operating in the diabetic gastroparesis treatment market report are Cardinal Health Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Ipca Laboratories Ltd., Abbott Laboratories, GlaxoSmithKline plc, AstraZeneca plc, Medtronics plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Kimberly-Clark Corporation, Teva Pharmaceutical Industries Ltd., Janssen Global Services LLC, Boston Scientific Corporation, Fresenius Kabi AG, Bausch Health Companies Inc., Allergan Inc., Salix Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Wockhardt Ltd., ANI Pharmaceuticals Inc., Endologic LLC, Vanda Pharmaceuticals Inc., Rhythm Pharmaceuticals Inc., Theravance Biopharma Inc., Neurogastrx Inc., Evoke Pharma Inc., CinRx Pharma LLC

Surgical Advancements And Diabetic Gastroparesis Fueling Growth In Treatment Strategies
The rising number of surgical procedures is expected to propel the growth of the diabetic gastroparesis treatment market going forward. Surgery refers to a medical specialty and branch of medicine that involves the treatment of diseases, injuries, or conditions through operative procedures. Surgical procedures in diabetic patients that have caused post-surgical gastroparesis include Nissen fundoplication, gastrectomy, gastric bypass surgery, pancreatectomy, vagotomy, and cholecystectomy by injuring the vague nerve that coordinates food movement through the digestive tract. For instance, in April 2022, according to the Aesthetic Society, a US-based industry organization of plastic surgeons, surgical aesthetic procedures increased by 54% in 2021 as compared to 2020. On average, a surgeon performed 320 procedures in 2021, up from 220 procedures in 2020. Therefore, the rising number of surgical procedures drives the diabetic gastroparesis treatment market.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/diabetic-gastroparesis-treatment-global-market-report

Key Segments -
The diabetic gastroparesis treatment market covered in this report is segmented -
1) By Treatment: Medication, Surgery
2) By Route Of Administration: Oral, Injectables
3) By Indication: Compensated Gastroparesis, Gastric Failure
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.